About this episode

Dr Amir Fathi and Dr Eunice S Wang discuss key clinical trial data on menin inhibitors for AML management.

Dr Amir Fathi from Massachusetts General Hospital in Boston, Massachusetts, and Dr Eunice S Wang from Roswell Park Comprehensive Cancer Center in Buffalo, New York, discuss key clinical trial data surrounding the use of menin inhibitors in the management of AML. CME information and select publications here .

More episodes of Hematologic Oncology Update

• CELMoDs for Multiple Myeloma — Microlearning Activity 2 with Dr Paul G Richardson · April 10, 2026 · 25 min
• Immune Thrombocytopenia — Microlearning Activity 4 with Dr Hanny Al-Samkari: ASH 2025 Review · April 1, 2026 · 25 min
• CELMoDs for Multiple Myeloma — Microlearning Activity 1 with Dr Paul G Richardson · March 23, 2026 · 24 min
• Immune Thrombocytopenia — Microlearning Activity 3 with Dr Hanny Al-Samkari: ASH 2025 Review · March 21, 2026 · 29 min
• CD19 x CD3 BiTEs for Acute Lymphoblastic Leukemia — An Interview with Dr Bijal Shah · March 13, 2026 · 1h 3m
• Chronic Lymphocytic Leukemia — An Interview with Prof Constantine Tam on Key Presentations from the 2025 ASH Annual Meeting · March 11, 2026 · 47 min

Explore listener stats, chart rankings, contacts and more on the Hematologic Oncology Update podcast page.